• Targeting 2 Proteins in Lungs, Including Cannabinoid Receptor, is Potential Therapy for IPF
  • The Travails of Dealing with Supplemental Oxygen
  • International Pulmonary Fibrosis Summit Scheduled for November in Nashville
  • Antacid Therapy May Lead to Lung Infections in Esbriet-Treated IPF Patients, Study Reports
  • Boehringer Ingelheim Enrolls First PF-ILD Patient in Phase 3 Trial of Ofev Therapy
  • To My Friends Who Don’t Have Answers to My Big Questions, I’m Sorry
  • ProMetic’s Therapy for IPF Receives FDA Approval for More Clinical Trials
  • Bristol-Myers, Nordic to Collaborate on Development of Fibrosis Disease Biomarkers
  • Changing Vision in a PF Patient, and What Can Help
  • Holding Tight to What’s Positive Up Ahead
  • Esbriet Equals Prednisone and Tops Acetylcysteine as Treatment for Pulmonary Fibrosis in Rats
  • It’s Not as Cute as a Service Dog, But Please Don’t Touch My Oxygen Tank